Low‐Frequency Deep Brain Stimulation in Non‐Rapid Eye Movement Sleep Modifies Memory Retention in Parkinson's Disease
Movement Disorders · 2025-02 · 40 (2) · 285-291
DOI: 10.1002/mds.30064 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Movement Disorders, online erschienen am 21.11.2024. Verfasst von Damian M Herz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Focus Program Translational Neuroscience (FTN), Rhine-Main Neuroscience Network (rmn2), University Medical Center of the Joh…. Hauptthemen laut MEDLINE: Parkinson Disease, Deep Brain Stimulation, Memory Consolidation, Memory Disorders. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: GBA Innovationsfondsproject.
Abstract (Originalsprache)
Background and Objective Memory impairment is a frequent and debilitating symptom in neurodegenerative disorders. The objective of this study was to provide proof‐of‐principle that deep brain stimulation during sleep can modify memory consolidation in people with Parkinson's disease depending on the stimulation frequency that is applied.
Methods
Twenty‐four patients with Parkinson's disease who were treated with deep brain stimulation of the subthalamic nucleus were included in this single‐blind pilot study. Six patients had to be excluded because of insomnia on the night of testing. Patients were randomized (1:1 ratio) to receiving either low frequency deep brain stimulation (4 Hz) or clinically used high frequency deep brain stimulation (130 Hz) during early non‐rapid eye movement (NREM) sleep. The main outcome measure was overnight memory retention as measured by a validated declarative memory task.
Results
Patients receiving low frequency deep brain stimulation during early NREM sleep (n = 9, 4 females, mean age 61.1 ± 4.3 years) showed improved overnight memory retention ( z = 2.549, P = 0.011). Patients receiving clinically used high frequency deep brain stimulation (n = 9, 2 females, mean age 62.2 ± 7.1) did not show any improvement ( z = 1.023, P = 0.306) leading to a significant difference between groups ( z = 2.214, P = 0.027). Stronger improvement in memory function was correlated with increased cortical low frequency activity after low frequency deep brain stimulation as measured by electroencephalography (ρ = 0.711, P = 0.037).
Conclusion
These results provide proof‐of‐principle that memory can be modulated by frequency‐specific deep brain stimulation during sleep. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Focus Program Translational Neuroscience (FTN), Rhine-Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
- Department of Neurology, Saarland University Clinic, Saarland, Germany.
ORCID-Profile: Damian M Herz, Gabriel Gonzalez-Escamilla
Förderung
- GBA Innovationsfondsproject
Zitieren
APA
Herz, D. M., Blech, J., Winter, Y., Gonzalez-Escamilla, G., & Groppa, S. (2025). Low‐Frequency Deep Brain Stimulation in Non‐Rapid Eye Movement Sleep Modifies Memory Retention in Parkinson's Disease. Movement Disorders, 40(2), 285-291. https://doi.org/10.1002/mds.30064
Vancouver
Herz DM, Blech J, Winter Y, Gonzalez-Escamilla G, Groppa S. Low‐Frequency Deep Brain Stimulation in Non‐Rapid Eye Movement Sleep Modifies Memory Retention in Parkinson's Disease. Movement Disorders. 2025;40(2):285-291. doi:10.1002/mds.30064
BibTeX
@article{Herz2025,
author = {Herz, Damian M and Blech, Jenny and Winter, Yaroslav and Gonzalez-Escamilla, Gabriel and Groppa, Sergiu},
title = {Low‐Frequency Deep Brain Stimulation in Non‐Rapid Eye Movement Sleep Modifies Memory Retention in Parkinson's Disease},
journal = {Movement Disorders},
year = {2025},
volume = {40},
number = {2},
pages = {285--291},
doi = {10.1002/mds.30064}
}
EUVIMED